No description available.

Purpose The objective of this study is to investigate how the reregulation affected the decision making process of buyers of OTC drugs, and to identify determinants for how a buyer chooses to obtain OTC drugs in the reregulated Swedish pharmacy market. Furthermore this study aims to map out buyers’ purchases of OTC drugs as well as their impressions about the reregulation of the Swedish pharmacy market   Background The Swedish pharmacy market was opened up for competition the 1 July 2009. On 1 November 2009, private pharmacies are allowed in the market, as well non-pharmacy retailers can commercialize OTC drugs. Thus due to the reregulation of the pharmacy market, consumers and retailers face a different market situation, since the amount of retailer selling OTC drugs has increased. This study investigates how buyers’ purchase behavior of OTC was affected by the end of the pharmacy monopoly.   Method  The purpose of this thesis was achieved by using a mixed-method approach. The qualitative method in the form of interviews and the quantitative method by conducting a survey. The mixed-method was used in order to obtain a deeper understanding of the phenomenon of consumer decision-making process as well as attitude and impression about the reregulation of the Swedish pharmacy market.   Conclusion Buyers are in general satisfied with the reregulation of the Swedish pharmacy market. However, the positive attitude towards the reregulation does not necessarily mean a change in purchase behavior for OTC drugs. The decision making process is found to be dependent on the level of experience the buyer possesses with the needed OTC drug, as well as the type of need the buyer experiences, thus three determinants for the decision making process of OTC drugs were found. The frequency of purchase is connected to the gender and age group of the buyer. Also the majority of the researched buyers already had experienced the purchase of OTC drugs in store other than pharmacies. The buyers that never purchase OTC drugs in other retailers are in general open to the possibility of taking advantage of those stores.

This thesis makes use of the unique reregulation of pharmaceutical monopoly in Sweden to critically examine intraindustry firm heterogeneity. It contributes to existing divestiture research as it studies the dynamism in between reconfigurations of value constellations and its effects on value creation of divested pharmacies. Because the findings showed that the predominant theory of intraindustry firm heterogeneity could not explain firm performance, the value constellation concept was applied as it captured the phenomena. A patterned finding informed how reconfigurations of value constellations in a reregulated market characterized by strict rules, regulations, and high competition did not generate additional value for firms on short term. My study unveils that value creation is hampered in situations where rules and regulations significantly affect firms’ ability to reconfigure their value constellations. The key practical implication is an alternative perspective on fundamental aspects of the reregulation and how policy-makers may impede firm performance and the intended creation of new value for not only firms but for society as a whole. / <p>Grade: A</p>

This thesis makes use of the unique reregulation of pharmaceutical monopoly in Sweden to critically examine intraindustry firm heterogeneity. It contributes to existing divestiture research as it studies the dynamism in between reconfigurations of value constellations and its effects on value creation of divested pharmacies. Because the findings showed that the predominant theory of intraindustry firm heterogeneity could not explain firm performance, the value constellation concept was applied as it captured the phenomena. A patterned finding informed how reconfigurations of value constellations in a reregulated market characterized by strict rules, regulations, and high competition did not generate additional value for firms on short term. My study unveils that value creation is hampered in situations where rules and regulations significantly affect firms’ ability to reconfigure their value constellations. The key practical implication is an alternative perspective on fundamental aspects of the reregulation and how policy-makers may impede firm performance and the intended creation of new value for not only firms but for society as a whole. / <p>Betyg: A</p>

Research Question: Does the pharmacy market seem to change in accordance with the goals stipulated by the government due to the reregulation? This leads to the following sub-questions: Does it seem like the availability of medical drugs for consumers increase? Does it seem like service for consumers get enhanced? Does it seem like the supply of services for consumers increase? Does it seem like the costs of medical drugs are maintained? Purpose: The purpose of this study is to evaluate if the trends resulting from the reregulation of the pharmacy monopoly correspond to the goals stipulated by the government. The purpose is furthermore to compare the reregulation of other Swedish markets and the reregulation of the pharmacy market in other Nordic countries in order to heed their lessons. Method: This study uses method triangulation, with a questionnaire directed to pharmacy customers forming the quantitative basis and interviews with specialists regarding the pharmacy market, forming the qualitative. The study also draws heavily on historic data regarding reregulation of Swedish markets and reregulation of the pharmacy market in other Nordic countries. Conclusions: Availability of medical drugs has increased and will presumably continue to do so.  Service quality has increased somewhat and will presumably continue to do so. Supply of services has increased and it will presumably continue to do so. The cost of medical drugs will only increase if it is required in order to satisfy the other goals.

Syftet med uppsatsen är att undersöka hur de anställda har upplevt apoteksmarknadens omreglering samt hur förändringarna har kommit att påverka dem. Uppsatsen behandlar omregleringen genom att kritiskt granska de främst framträdande konsekvenserna för arbetstagarna, hur dessa har hanterats samt vilka motivationsfaktorer som legat till grund under förändringen. Den bakomliggande anledningen till varför jag valt att studera hur de anställda upplevt omregleringen av apoteksmarknaden, beror på att forskningen kring hur personalen påverkas av avreglering, omregleringar och liberaliseringar av olika marknader ännu inte är utforskad i Sverige. Det empiriska material studien grundar sig på är insamlat från två apoteksverksamheter i Värmland där de intervjuade respondenterna arbetat och fortfarande arbetar inom apoteksverksamheter som blivit uppköpta av nya ägare. Urvalet av respondenter skedde genom telefonkontakt och förfrågan om personal som kunde tänka sig att ställa upp på intervju. Materialet har sedan analyserats genom teorier som berör områdena för förändringsarbete, motivation samt psykosocial arbetsmiljö. Studiens resultat och slutsatser visar att apoteksmarknadens omreglering bidragit med konsekvenser för de anställda rörande ökade krav på arbetet, stress samt viss oro inför ökad konkurrens på arbetsmarknaden kring hur det kommer att påverka arbetstryggheten i framtiden. Vidare upplevdes förändringen även bidra med utökade möjligheter för vidareutveckling i arbetet, utökade ansvarbefogenheter samt nya utmaningar, vilket ses upplyftande. För att hantera förändringsarbetet har den sociala dimensionen i kombination med uppskattning i arbetet, främst legat till grund för fortsatt motivation i och med förändringarna. / The purpose of this paper is to investigate how the employees have experienced the reregulation of the pharmacy market, and how the changes have affected them. The essay deals with reregulation by critically examining the foremost prominent impact on the workers, how they were handled and what the motivation factors that formed the basis during the change. The underlying reason for why I have chosen to study how the employees experienced the reregulation of the pharmacy market, is because the research on how employees are affected by deregulation, reregulation and liberalization of markets has not yet been explored in Sweden. The empirical material that is based on the study is collected from two pharmacy companies in Värmland, where the interviewed respondents worked and are still working in the pharmacy companies that have been bought by new owners. The selection of respondents was made by telephone contact and requests for staff that would be willing to do an interview. The material is then analyzed through theories related to the fields of change management, motivation, and psychosocial work environment. The results and conclusions of the study show that the pharmacy market reregulation contributed to the impact on employees regarding increased demands at work, stress, and some concern about increased competition in the labour market on how job security will be affected in the future. The change was also felt to contribute to enhanced opportunities for further development of work, increased responsibility and powers of new challenges, which is considered uplifting. To manage the change process, the social dimension in combination with appreciation, has been the underlying basis for continued motivation with the changes.

本論文共分七章二十七節。主要內容如下： 第一章為緒論。說明撰寫本論文之動機和目的、研究方法、範圍暨限制以及論文架構。 第二章為金融創新之本質與金融商品開放之理由。介紹金融創新的定義、種類、源起及發展，並探討外匯期貨暨選擇權在金融創新中之歸類、定位，以及金融商品應開放之理由。 第三章為我國現行的外匯管理制度及避險工具。首先說明我國目前外匯管理制度的特色，其次就外匯風險之類型加以分類，並介紹我國現有之主要匯率避險工具－遠期外匯暨其它匯率避險工具，最後則針對我國遠期外匯市場交易清淡之原因進行探討。 第四章為外匯期貨契約。除了介紹外匯期貨契約的起源、經濟功能及法律概念與規範意義外，並對保證金之制度及法律性質加以說明。另外，則對美、日、新加坡之外匯期貨交易制度進行比較，並特別介紹互相結轉沖銷系統(MOS)及全球交易系統 (Globex)。最後，則針對外匯期貨交易中之避險及投機操作，逐一舉例說明分析。 第五章為外匯選擇權契約。本章首先介紹外匯選擇權之起源、定義及種類；接著說明其法律性質、規範意義與實務操作，並綜合比較遠期外匯、外匯期貨暨選擇權；最後則對我國國外期貨交易法加以評釋。 第六章為金融規範分析-Laffer Curve 於政府修法時之應用。本章為法律之經濟分析，筆者嘗試將成本效益分析、博弈理論(Game Theory)及諮商(Negotiation)策略應用到政府之立法上面。探討法令規範之最適規模及其與時間函數之關係，並檢討「立法從嚴、執法從寬」暨「惡法亦法」之不當。 第七章為結論與建議。本章以摘要方式將前述章節內容做一總結，並對正草擬中之國內期貨交易法提出筆者淺見，俾供參考。 / GATT is the most important organization which governedrld trade since it was founded in 1948. since China15th trader in the world,so it certainly cannotutside of GATT.China's special case has given rise to certain legalonomic problems,which have made its participation intill remain unsolved.legal issues come from China's request for "resumptioninal membership".This request will cause difficult whens to some rights and obligations under GATT such asion ticket,grandfather clause and non-application clause.ms GATT will "acknowledge" China's orginal seat,butneeds to negotiate is terms and obligations as a newant.economic problems are caused by China's non-marketic system and its claim for developing country status.hough China has carried out many reforms on economicure,major GATT contracting parties still think China'sy and trade regime are not liberlized enough to fit GATT.ina's great potential export power makes other countriesant to give China special treatment which other developingies enjoy.to China's reform of its trade system,China only has toake tariff concession without undertaking other importments which some East European countries have made. Chinareally like to avoid discriminatory quantity restriction special safeguard clauses,but other contracting partiest likely to permit this.use of changes in international circumstances, theation of China's participation has made no progress during991.After 1992,the negotiation begin to accelerate,butcan' t reach a certain conclusion.

This bachelor’s thesis is about the reregulation of the Swedish pharmacy monopoly that occurred in July 2009. The study is examining the intentions of the reregulation, the Swedish pharmacy market as it is today and if there seems to be a correlation between these. The theory used for the study is the policy process and it serves as a way for the reader to gain a deeper understanding of the process between the preparations of the decision, and the evaluation of the solution that was implemented.  Through a policy analysis and by looking at documents carried out by government authorities the analysis lifts the intentions of the reregulation by interpreting its goals. By reading evaluating documents regarding the reregulation, it is possible to create a perception of the pharmacy market today. In the discussion the question regarding the correlation between these two is brought up and looked at. The result of the study shows that the outcome of the reregulation is not fully correlating to the intentions that was once written in preparing material for the decision. The reregulation was looking for efficiency, availability, lowering costs and creating a safe drug use for the costumers. After looking at the combined material not all goals have been achieved to its fullest.